Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

executive committee

4 posts
NNovartis
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
Read More

Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting

  • 2026-03-08
Novartis Pharma AG Shareholders approve 29th consecutive dividend increase to CHF 3.70 (+5.7%) per share for 2025, representing…
NNovartis
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
Read More

Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting

  • 2026-03-06
Novartis Pharma AG Shareholders approve 29th consecutive dividend increase to CHF 3.70 (+5.7%) per share for 2025, representing…
NNovartis
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
Read More

Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting

  • 2026-03-06
Novartis Pharma AG Shareholders approve 29th consecutive dividend increase to CHF 3.70 (+5.7%) per share for 2025, representing…
RRoche
Roche fenebrutinib Phase III hits PPMS disability goal
Read More

Roche Names Nina Schwab-Hautzinger Head of Group Communications

  • 2026-02-14
Roche (OTCQX: RHHBY) announced that Nina Schwab-Hautzinger (born 1975) will be appointed Head…
Switzerland
www.europesays.com